Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters

Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine

(2021) Tom Shimabukuro et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Stabilizing the closed SARS-CoV-2 spike trimer

(2021) Jarek Juraszek et al.   Nature Communications

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice

(2021) Jing-Hui Tian et al.   Nature Communications

Recombinant protein vaccines, a proven approach against coronavirus pandemics

(2021) Jeroen Pollet et al.   ADVANCED DRUG DELIVERY REVIEWS

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection

(2021) David S. Khoury et al.   NATURE MEDICINE

Side effect worry grows for AstraZeneca vaccine

(2021) Gretchen Vogel et al.   SCIENCE

SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus

(2021) Giulia Matusali et al.   Viruses-Basel

Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters

(2021) Qingmei Jia et al.   npj Vaccines

Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models

(2021) Kirill V. Kalnin et al.   npj Vaccines

A global database of COVID-19 vaccinations

(2021) Edouard Mathieu et al.   Nature Human Behaviour

A Whole Virion Vaccine for COVID-19 Produced via a Novel Inactivation Method and Preliminary Demonstration of Efficacy in an Animal Challenge Model

(2021) Izabela K Ragan et al.   Vaccines

Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines

(2021) Yoshikazu Honda-Okubo et al.   Pathogens

COVID-19 vaccines

(2021) Duduzile Ndwandwe et al.   CURRENT OPINION IN IMMUNOLOGY

COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead

(2021) Marguerite Massinga Loembé et al.   IMMUNITY

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

(2021) Jamie Lopez Bernal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection

(2021) Lei Li et al.   VACCINE

A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization

(2021) Isaac G. Sakala et al.   VACCINE

A truncated glycoprotein G vaccine formulated with Advax-CpG adjuvant provides protection of mice against genital herpes simplex virus 2 infection

(2021) Staffan Görander et al.   VACCINE

Evidence for antibody as a protective correlate for COVID-19 vaccines

(2021) Kristen A. Earle et al.   VACCINE

Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination

(2021) Han W. Kim et al.   JAMA Cardiology

Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines

(2021) Ai-ris Y. Collier et al.   NEW ENGLAND JOURNAL OF MEDICINE

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel

(2021) Dror Mevorach et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rapid development of analytical methods for evaluating pandemic vaccines: a COVID-19 perspective

(2021) Jeremy Baldwin et al.   Bioanalysis

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

(2020) Sin Fun Sia et al.   NATURE

Development of an inactivated vaccine candidate for SARS-CoV-2

(2020) Qiang Gao et al.   SCIENCE

DNA vaccine protection against SARS-CoV-2 in rhesus macaques

(2020) Jingyou Yu et al.   SCIENCE

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays

(2020) Katharine H. D. Crawford et al.   Viruses-Basel

Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies

(2020) Ivan Mercurio et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

(2020) Kizzmekia S. Corbett et al.   NATURE

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

(2020) Neeltje van Doremalen et al.   NATURE

Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development

(2020) Masaki Imai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

(2020) Thomas F. Rogers et al.   SCIENCE

Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1/Th2-Balanced) Adjuvant Despite Complete Viral Protection

(2020) Katherine M. Eichinger et al.   Frontiers in Immunology

Animal models for COVID-19

(2020) César Muñoz-Fontela et al.   NATURE

A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

(2020) Angkana T. Huang et al.   Nature Communications

COVID-19-neutralizing antibodies predict disease severity and survival

(2020) Wilfredo F. Garcia-Beltran et al.   CELL

Efficacy of an Adjuvanted Middle East Respiratory Syndrome Coronavirus Spike Protein Vaccine in Dromedary Camels and Alpacas

(2019) Danielle Adney et al.   Viruses-Basel

Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety

(2015) Nikolai Petrovsky et al.   VACCINE

Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology

(2014) Yoshikazu Honda-Okubo et al.   JOURNAL OF VIROLOGY